Skip to main content

Day: August 19, 2021

BRT Apartments Corp. Announces Completion of the Acquisition of Remaining Interest in Bells Bluff

– Also Announces Agreement to Acquire the Remaining Interest in Crestmont at Thornblade – – Strengthens Ownership Presence in Two High Growth Southeast Markets – GREAT NECK, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) — BRT Apartments Corp. (NYSE:BRT) today announced that it closed on the purchase of the remaining 41.9% interest of the joint venture entity that owns Bells Bluff, a 402-unit multi-family property located in West Nashville, TN, for approximately $28 million. As a result, Bells Bluff is now wholly-owned by BRT. In connection with the closing, BRT refinanced the variable rate mortgage debt on the property with 20-year fixed rate (i.e., 3.48%) mortgage debt in the principal amount of $52 million. The new mortgage debt is interest only until 2031. BRT also entered into an agreement to acquire the remaining 10% interest in the...

Continue reading

Airspan Networks Inc. Announces Strong Second Quarter 2021 Revenue Growth and 5G Business Update

Pre-Business Combination Quarterly Revenue of $42.0 million, up 51% Q2 21 vs. Q2 20 First Half Revenue of $88.0 million, increasing 59% 1H 21 vs. 1H 20 First half 2021 growth driven by contributions from 5G, Open RAN, and Fixed Wireless Access (“FWA”) solutions Business combination with New Beginnings Acquisition Corp. closed August 13, 2021, after the close of Q2BOCA RATON, Fla., Aug. 19, 2021 (GLOBE NEWSWIRE) — Airspan Networks Inc. (NYSE American: MIMO) (“Airspan”), which provides a groundbreaking next-generation 5G platform, today announced results for the quarter and six months ended June 30, 2021. On August 13, 2021, Airspan Networks Inc. became a subsidiary of Airspan Networks Holdings Inc. following closing of a previously announced business combination with New Beginnings Acquisition Corp. 2021 Second Quarter Highlights:Revenue...

Continue reading

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2021

Revenue of $220 million for Fiscal 2021 Fourth Quarter Adjusted EPS Increased 10.7% Year over Year SALT LAKE CITY, Aug. 19, 2021 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its fourth quarter and full fiscal year ended June 30, 2021. Fourth Quarter Fiscal 2021 Summary*:Revenue of $54.8 million, a decrease of 7.7% from the prior year period and an increase of 6.2% sequentially; Total active accounts decreased 5.0% compared to the prior period while increasing 1.2% sequentially to 170,000. The year over year decline includes a decline in distributors of 13.7%, partially offset by an increase of 0.9% in customers. Compared to the third quarter of fiscal 2021, the number of distributors was flat and customers grew by 1.9%; Earnings per diluted share were $0.35, up 34.6% over the...

Continue reading

Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow

WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its second quarter 2021 financial results after market close on Thursday, August 26, 2021. Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Second Quarter 2021 Results Conference Call Details:Date: Thursday August 26, 2021Time: 4:30 p.m. ETLive Call: 1-877-268-9044 (Canada and the United States) 1-706-679-2995 (International)   Replay: 1-404-537-3406Conference ID: 3026836 Webcast URL: https://edge.media-server.com/mmc/p/6dxyk8b7 The...

Continue reading

GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly

ATLANTA, GA, Aug. 19, 2021 (GLOBE NEWSWIRE) — GeoVax Vaccine Being Developed as a Universal Vaccine to Address Evolving SARS-CoV-2 Variants via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today presented data from ongoing studies of its preventive vaccine against COVID-19. The presentation titled, “Design of a Universal SARS-CoV-2 Vaccine Against Evolving Variants,” was delivered virtually by Mark J. Newman, Ph.D., GeoVax’s Chief Scientific Officer, during the European Society of Medicine (ESMED) General Assembly, being held August 19-21 in Berlin, Germany. First-generation SARS-CoV-2 vaccines were rapidly developed and have proven highly efficacious in the human population and were designed to encode the prefusion stabilized...

Continue reading

Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

WIXOM, Mich., Aug. 19, 2021 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that a majority of the independent directors serving on the Company’s Board of Directors approved the grant of an option to purchase 350,000 shares of the Company’s common stock to Megan C. Timmins, the Company’s Senior Vice President, General Counsel and Secretary (the “Inducement Grant”). The Inducement Grant has been granted outside of the Company’s 2018 Long Term Incentive Plan (“Plan”), but remains subject to the terms and conditions of such Plan. The Inducement Grant was granted as an inducement material to such individual’s...

Continue reading

CareTrust REIT Publishes Inaugural Corporate Social Responsibility Report

SAN CLEMENTE, Calif., Aug. 19, 2021 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (Nasdaq:CTRE) today published its inaugural Corporate Social Responsibility (CSR) Report, reflecting its commitment to provide regular and transparent reporting on the company’s environmental, social and governance (ESG) initiatives. “This first CSR Report, and the high level of accountability it reflects, is a major step in the process we began in 2019 to advance the company’s ESG priorities in our decision-making and reporting practices,” said Greg Stapley, CareTrust’s Chairman and Chief Executive Officer. Mr. Stapley noted that the company published a number of ESG-related policies in 2019 and 2020, all of which are available in the Investors section of the company’s website. “Although there is more that we are anxious to accomplish, we are excited about...

Continue reading

New Publication Date for Allarity Therapeutics’ Q2 2021 Interim Report

Press Release Hørsholm, Denmark (August 19, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced a new publication date for the Company’s Q2 2021 Interim Report, which is now being made public on August 23, 2021 (previously: August 31, 2021). The reason for the change of publication date is to accelerate the Company’s preparations for the transformation and recapitalization as announced on May 21, 2021 as the Company advances towards migration to listing on the U.S. Nasdaq stock market (New York, N.Y.). About Allarity Therapeutics Allarity Therapeutics (Nasdaq First North Growth Market Stockholm: ALLR.ST) develops drugs for personalized treatment of cancer guided by its proprietary drug response predictor technology, the DRP® platform. The Company has a mature portfolio of six drug candidates, including compounds...

Continue reading

Manufactured Housing Properties Inc. Announces Results for the Three and Six Months Ended June 30, 2021

– Revenues and EBITDA Increased 14% and 16%, respectively, Over Prior Period For the Quarter Ended June 30, 2021, And Revenues and EBITDA Increased 19% and 15%, respectively, Over Prior Period For the Six Months Ended June 30, 2021Charlotte, North Carolina, Aug. 19, 2021 (GLOBE NEWSWIRE) — Manufactured Housing Properties Inc. (OTC: MHPC), which acquires, owns, and operates 30 manufactured housing communities containing approximately 1,532 developed sites, today announced operating results for the quarter ended June 30, 2021. Total revenues and EBITDA for the quarter ended June 30, 2021 were $1,799,438 and $840,719, respectively, compared to $1,578,845 and $722,562, respectively, for the quarter ended June 30, 2020. Total revenues and EBITDA for the six months ended June 30, 2021 were $3,505,302 and $1,385,874, respectively,...

Continue reading

CENAQ Energy Corp. ANNOUNCES CLOSING OF FULL OVER-ALLOTMENT OPTION

Houston, TX, Aug. 19, 2021 (GLOBE NEWSWIRE) — CENAQ Energy Corp. (the “Company”) announced today that it has completed the sale of the full 2,250,000 units pursuant to the underwriters’ over-allotment option granted in connection with the Company’s initial public offering. Each unit consists of one share of the Company’s Class A common stock and three-quarters of one warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at an exercise price of $11.50 per share. The units sold pursuant to the over-allotment option were sold at an offering price of $10.00 per unit, generating gross proceeds of $22,500,000 to the Company. Of the proceeds received from the consummation of the initial public offering, including the over-allotment option, and simultaneous private placements of units, $174,225,000...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.